The molecular mechanisms were explored by evaluating the PTEN/PI3K/AKT/mTOR pathway and omental macrophage profiles using Western blot, ELISA, and immunohistochemistry.<h4>Results</h4>CHWD treatment significantly ameliorated HFD-induced body weight gain, dyslipidemia, and hepatic steatosis. Here, MTOR is linked to metabolic syndrome.